Dr. Brittany Knick Ragon, MD

Dr. Ragon practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Ragon's NPI, 1598057986, was assigned on May 4, 2011. Dr. Ragon graduated from School of Medicine Columbia in 2011. Dr. Ragon holds North Carolina license 2017-01144.

Dr. Ragon's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Ragon's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Ragon is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Levine Cancer Institute. Dmand AI also links Dr. Ragon to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ragon practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ragon's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Ragon is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Ragon's licenses on file in 3 states: North Carolina, Texas and Tennessee.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Ragon treats.

CMS data shows 136 Medicare services from Dr. Ragon across 2 procedure codes in 2024, all of them office visits, for 41 Medicare patients. Medicare paid $11,182 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 41 Medicare patients who saw Dr. Ragon in 2024. The largest group is 75 to 84, with 16 patients. 68% of them have high blood pressure, and 59% have high cholesterol. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ragon's median patient age at 70, with 53% women.

In 2024, Dr. Ragon wrote 379 Medicare Part D claims for 40 patients. 75% of them were for generic drugs. CMS names the drug for 249 of them, across 11 drugs with 11 or more claims each, at $638,459 in total drug cost. In 2023, CMS named 255 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ragon for performance year 2024, reported as part of a group. Dr. Ragon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ragon as offering telehealth.

Dmand AI links 32 papers to Dr. Ragon, published from 2013 to 2025. 2017 was the busiest year, with 5. The most frequent topics are Leukemia, Myeloid, Acute, Graft vs Host Disease and Hematologic Neoplasms. Dr. Ragon has published most often in Clin Lymphoma Myeloma Leuk. Dr. Ragon's most frequent co-authors are Michael Richard Grunwald, MD, Jing Ai, MD and Thomas Gregory Knight, MD.

Dmand AI links Dr. Ragon to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Myelodysplastic Syndromes.

CMS Open Payments shows 27 general payments to Dr. Ragon from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. Syndax Pharmaceuticals, Inc. paid the most, $11,529.

Dmand AI lists 8 awards for Dr. Ragon, most recently Alpha Omega Alpha Honor Society in 2010.

Dr. Ragon graduated from School of Medicine Columbia in 2011. Dr. Ragon is a member of AACR, ASCO, ASH and American Society of Transplantation and Cellular Therapy.

Dr. Ragon is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.